Skip to main content

Table 2 PTV dose-constraints and indexes for each patient

From: Contribution of three-dimensional conformal intensity-modulated radiation therapy for women affected by bulky stage II supradiaphragmatic Hodgkin disease

Patient

V95%

D98%

D50%

D2%

CI

HI

CO

3D-CRT

IMRT HT

3D-CRT

IMRT HT

3D-CRT

IMRT HT

3D-CRT

IMRT HT

3D-CRT

IMRT HT

3D-CRT

IMRT HT

3D-CRT

IMRT HT

1

95.6

96.2

91.3

93.05

102

99.9

106.6

104.1

2.3

1.2

1.1

1.1

0.6

0.8

2

96.8

94,9

92.9

90.7

100.7

99.9

104.7

102.8

2.4

1.1

1.1

1.1

0.7

0.8

3

92.3

98.1

82.5

95.2

100

100

104.4

103.05

2.3

1.3

1.1

1.1

0.5

0.7

4

94.3

99.4

92.3

97.8

99.4

100.1

107.3

102.1

2.8

1.3

1.1

1.1

0.8

0.9

5

91.9

97.5

90.4

94.4

99.1

99.8

105

102.3

2.3

1.3

1.1

1.1

0.6

0.7

6

76.8

94.6

86.3

90.6

97.7

101.2

104.7

105.8

2.6

1.3

1.1

1.1

0.4

0.7

7

94.5

95.3

88.1

92.3

103.05

100

106

101.6

2.8

1.1

1.2

1.1

0.6

0.8

8

92.2

94.9

87.5

91.1

101.6

100

108.6

102.9

2.4

1.1

1.1

1.1

0.5

0.7

9

96.1

94.3

93.3

90.5

99.6

99.7

103.7

102.9

2.4

1.1

1.1

1.1

0.6

0.8

10

94.1

96.8

90.8

93

99.8

99.7

104.5

102.5

2.3

1.3

1.1

1.1

0.7

0.7

11

97.8

94.1

94.6

90

101.7

99.8

104.9

103

3.1

1.1

1.1

1.1

0.5

0.7

12

97.2

95.1

93.7

91.6

102

100

106.6

103.4

3.0

1.1

1.1

1.1

0.8

0.8

13

97.7

94.5

94.5

90.5

101.4

99.8

105.4

102.9

3.0

1.2

1.1

1.1

0.8

0.8

mean

93.7

95.8

90.6

92.4

100.6

100

105.6

103

2.6

1.2

1.1

1.1

0.6

0.8

median

94.5

95.1

91.3

91.6

100.7

99.9

105

102.9

2.4

1.2

1.1

1.1

0.6

0.8

(p)

NS

NS

NS

0.002

0.001

NS

0.001